Back to company

IMMUNITRACK ApS: Financial statements 2022

CVR: 32347908

IMMUNITRACK ApS (CVR 32347908) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 5,476,278 and a net result of DKK 1,175,601 compared with DKK 256,541 the year before. That is an increase of 20.8% compared with the year before. Equity amounted to DKK 10,159,857. The solvency ratio was 65.3%. The company had 11 employees in the financial year.

Gross Profit
5,476,278 kr.
Profit/Loss
1,175,601 kr.
Equity
10,159,857 kr.
Total Assets
15,549,709 kr.
Employees
11

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-5.5 mio.1.2 mio.10.2 mio.11
2021-4.5 mio.257 t.7.7 mio.9
2020-1.1 mio.-1.2 mio.4.9 mio.8
2019--457 t.-2.3 mio.6.1 mio.6
2018-2.5 mio.1.7 mio.3.5 mio.4

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on IMMUNITRACK ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

About IMMUNITRACK ApS

IMMUNITRACK ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2013. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 6 employees. In 2024, the company reported a gross profit of DKK 141,975,865 and a net result of DKK 110,009,470 compared with DKK -194,097 the year before. Equity amounted to DKK 21,211,816.